Transcatheter Aortic Valve Replacement (TAVR) Market Research Report Information By Procedure (Transfemoral Implantation, Transapical Implantation, and Transaortic Implantation), By End Users (Hospitals, Ambulatory Surgical Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE

6.1. Overview

6.2. Transfemoral Implantation

6.3. Transapical Implantation

6.4. Transaortic Implantation

7. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER

7.1. Overview

7.2. Hospitals

7.3. Ambulatory Surgical Centers

7.4. Others

8. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Transcatheter Aortic Valve Replacement (TAVR) Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Transcatheter Aortic Valve Replacement (TAVR) Market,

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger &Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2023

9.8.2. Major Players R&D Expenditure.2023

10. COMPANY PROFILES

10.1. CryoLife, Inc. (U.S.)

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Abbott (U.S.)

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Micro Interventional Devices, Inc. (U.S.).

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Boston Scientific Corporation (U.S.)

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. LIVANOVA PLC (U.K.)

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Meril Life Sciences Pvt. Ltd. (India)

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Edwards Lifesciences Corporation (U.S.)

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Medtronic (Ireland)

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Auto Tissue Berlin GmbH (Germany)

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Lepu Medical Technology Co. Ltd. (China)

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Products Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Neovasc Inc. (Canada)

10.11.1. Company Overview

10.11.2. Financial Overview

10.11.3. Products Offered

10.11.4. Key Developments

10.11.5. SWOT Analysis

10.11.6. Key Strategies

10.12. TTK HealthCare (India)

10.12.1. Company Overview

10.12.2. Financial Overview

10.12.3. Products Offered

10.12.4. Key Developments

10.12.5. SWOT Analysis

10.12.6. Key Strategies

10.13. JenaValve Technology, Inc. (Germany)

10.13.1. Company Overview

10.13.2. Financial Overview

10.13.3. Products Offered

10.13.4. Key Developments

10.13.5. SWOT Analysis

10.13.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, ESTIMATES &FORECAST, 2019-2032(USD BILLION)

TABLE 3 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 7 US: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 8 US: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 9 CANADA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 10 CANADA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 3 GERMANY: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 5 FRANCE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 6 FRANCE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 7 ITALY: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 8 ITALY: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 9 SPAIN: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 10 SPAIN: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 11 UK: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 12 UK: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 17 JAPAN: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 18 JAPAN: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 19 CHINA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 20 CHINA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 21 INDIA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 22 INDIA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 23 AUSTRALIA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 24 AUSTRALIA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 33 AFRICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 34 AFRICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET

FIGURE 4 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY PROCEDURE, 2023

FIGURE 5 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY END USER, 2023

FIGURE 6 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023

FIGURE 7 NORTH AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 REST OF THE WORLD: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 12 CRYOLIFE, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 CRYOLIFE, INC. (U.S.): SWOT ANALYSIS

FIGURE 14 ABBOTT (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ABBOTT (U.S.): SWOT ANALYSIS

FIGURE 16 MICRO INTERVENTIONAL DEVICES, INC. (U.S.).: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 MICRO INTERVENTIONAL DEVICES, INC. (U.S.).: SWOT ANALYSIS

FIGURE 18 BOSTON SCIENTIFIC CORPORATION (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 BOSTON SCIENTIFIC CORPORATION (U.S.): SWOT ANALYSIS

FIGURE 20 LIVANOVA PLC (U.K.).: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 LIVANOVA PLC (U.K.): SWOT ANALYSIS

FIGURE 22 MERIL LIFE SCIENCES PVT. LTD. (INDIA): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 MERIL LIFE SCIENCES PVT. LTD. (INDIA): SWOT ANALYSIS

FIGURE 24 EDWARDS LIFESCIENCES CORPORATION (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 EDWARDS LIFESCIENCES CORPORATION (U.S.): SWOT ANALYSIS

FIGURE 26 MEDTRONIC (IRELAND): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 MEDTRONIC (IRELAND): SWOT ANALYSIS

FIGURE 28 AUTO TISSUE BERLIN GMBH (GERMANY): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 AUTO TISSUE BERLIN GMBH (GERMANY): SWOT ANALYSIS

FIGURE 30 LEPU MEDICAL TECHNOLOGY CO. LTD. (CHINA): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 LEPU MEDICAL TECHNOLOGY CO. LTD. (CHINA): SWOT ANALYSIS

FIGURE 32 NEOVASC INC. (CANADA): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 NEOVASC INC. (CANADA): SWOT ANALYSIS

FIGURE 34 TTK HEALTHCARE (INDIA): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 TTK HEALTHCARE (INDIA): SWOT ANALYSIS

FIGURE 36 JENAVALVE TECHNOLOGY, INC. (GERMANY): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 JENAVALVE TECHNOLOGY, INC. (GERMANY): SWOT ANALYSIS